Company’s 36-month beta value is 1.05.Analysts have differing opinions on the stock, with 2 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for GH is 116.04M, and currently, short sellers hold a 8.24% ratio of that floaft. The average trading volume of GH on May 09, 2024 was 1.92M shares.
GH) stock’s latest price update
Guardant Health Inc (NASDAQ: GH) has seen a decline in its stock price by -0.96 in relation to its previous close of 18.82. However, the company has experienced a 2.08% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-05-07 that Investors’ focus will likely be on revenues generated by Guardant Health (GH) from its precision oncology testing business.
GH’s Market Performance
GH’s stock has risen by 2.08% in the past week, with a monthly drop of -2.92% and a quarterly drop of -15.58%. The volatility ratio for the week is 3.46% while the volatility levels for the last 30 days are 5.04% for Guardant Health Inc The simple moving average for the last 20 days is 4.79% for GH stock, with a simple moving average of -27.48% for the last 200 days.
Analysts’ Opinion of GH
Many brokerage firms have already submitted their reports for GH stocks, with Craig Hallum repeating the rating for GH by listing it as a “Buy.” The predicted price for GH in the upcoming period, according to Craig Hallum is $28 based on the research report published on April 24, 2024 of the current year 2024.
GH Trading at 1.70% from the 50-Day Moving Average
After a stumble in the market that brought GH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -54.60% of loss for the given period.
Volatility was left at 5.04%, however, over the last 30 days, the volatility rate increased by 3.46%, as shares sank -2.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -4.56% lower at present.
During the last 5 trading sessions, GH rose by +2.08%, which changed the moving average for the period of 200-days by -49.59% in comparison to the 20-day moving average, which settled at $17.76. In addition, Guardant Health Inc saw -31.09% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GH starting from Kalia Kumud, who purchase 2,187 shares at the price of $17.82 back on Mar 18 ’24. After this action, Kalia Kumud now owns 12,722 shares of Guardant Health Inc, valued at $38,963 using the latest closing price.
Joyce Meghan V., the Director of Guardant Health Inc, sale 100 shares at $19.05 during a trade that took place back on Mar 04 ’24, which means that Joyce Meghan V. is holding 4,521 shares at $1,905 based on the most recent closing price.
Stock Fundamentals for GH
Current profitability levels for the company are sitting at:
- -1.0 for the present operating margin
- 0.85 for the gross margin
The net margin for Guardant Health Inc stands at -0.85. The total capital return value is set at -0.36. Equity return is now at value -438.13, with -28.23 for asset returns.
Based on Guardant Health Inc (GH), the company’s capital structure generated 0.88 points at debt to capital in total, while cash flow to debt ratio is standing at -0.28. The debt to equity ratio resting at 7.36. The interest coverage ratio of the stock is 219.06.
Currently, EBITDA for the company is -519.63 million with net debt to EBITDA at -0.41. When we switch over and look at the enterprise to sales, we see a ratio of 4.41. The receivables turnover for the company is 6.35for trailing twelve months and the total asset turnover is 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.54.
Conclusion
In a nutshell, Guardant Health Inc (GH) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
